The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Salbul 100 micrograms/dose pressurised inhalation, suspension

100 microgram(s) Pressurised inhalation, suspension

Rowex LtdPA0711/128/001

Main Information

Trade NameSalbul 100 micrograms/dose pressurised inhalation, suspension
Active SubstancesSalbutamol
Strength100 microgram(s)
Dosage FormPressurised inhalation, suspension
Licence HolderRowex Ltd
Licence NumberPA0711/128/001

Group Information

ATC CodeR03AC Selective beta-2-adrenoreceptor agonists
R03AC02 salbutamol


Licence Issued13/11/2009
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0078-138-053
Interchangeable List DocumentPDF of Interchangeable List
« Back